Fulgent Genetics (NASDAQ:FLGT)
Historical Stock Chart
2 Years : From Dec 2017 to Dec 2019
Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”) today announced that its Chairman and Chief Executive Officer Ming Hsieh and its Chief Financial Officer Paul Kim are scheduled to participate in the 30th Annual Piper Jaffray Healthcare Conference on Wednesday, November 28, 2018 at the Lotte New York Palace Hotel in New York, New York.
These representatives of the company will participate in in a question-and-answer session with the host analyst beginning at approximately 3:00 p.m. ET.
A live webcast of the question and answer session will be available on the Investor Relations section of the Fulgent Genetics website at ir.fulgentgenetics.com. A replay of the webcast will be accessible at ir.fulgentgenetics.com beginning approximately one hour following the completion of the event.
About Fulgent Genetics
Fulgent Genetics is a technology company with a focus on offering comprehensive genetic testing to provide physicians with clinically actionable diagnostic information they can use to improve the quality of patient care. The company has developed a proprietary technology platform that allows it to offer a broad and flexible test menu and continually expand and improve its proprietary genetic reference library, while maintaining accessible pricing, high accuracy and competitive turnaround times. The company believes its test menu, which currently offers more genes for testing than its competitors in today’s market, enables it to provide expansive options for test customization and clinically actionable results.
Investor Relations Contacts:The Blueshirt GroupNicole Borsje, 415-217-2633, email@example.com